2016
DOI: 10.1136/archdischild-2015-309789
|View full text |Cite
|
Sign up to set email alerts
|

The importance of early involvement of paediatric palliative care for patients with severe congenital heart disease

Abstract: Growing numbers of patients with severe congenital heart disease (CHD) are surviving into late childhood and beyond. This increasingly complex patient group may experience multiple formidable and precarious interventions, lifelong morbidity and the very real risk of premature death on many occasions throughout their childhood. In this paper, we discuss the advantages of a fully integrated palliative care ethos in patients with CHD, offering the potential for improved symptom control, more informed decision-mak… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
30
0
10

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(41 citation statements)
references
References 36 publications
(39 reference statements)
1
30
0
10
Order By: Relevance
“…Emerging evidence suggests there is some negative life experience and a variable impact on quality of life for those living with a Fontan circulation [392,393], but a positive outlook and focus on remaining healthy are common [392]. Although there is evidence from randomised trials that shows improved quality of life, less depression, and greater spiritual wellbeing with palliative care for those with advanced non-congenital HF [394], there are few data to directly guide palliative care for those with a Fontan circulation [395]. Although not an ideal predictor of death, a suggested pragmatic approach to involving palliative care is to ask clinicians to reflect on the question, ''Would I be surprised if this patient died in the next 12 months?".…”
Section: Overviewmentioning
confidence: 99%
“…Emerging evidence suggests there is some negative life experience and a variable impact on quality of life for those living with a Fontan circulation [392,393], but a positive outlook and focus on remaining healthy are common [392]. Although there is evidence from randomised trials that shows improved quality of life, less depression, and greater spiritual wellbeing with palliative care for those with advanced non-congenital HF [394], there are few data to directly guide palliative care for those with a Fontan circulation [395]. Although not an ideal predictor of death, a suggested pragmatic approach to involving palliative care is to ask clinicians to reflect on the question, ''Would I be surprised if this patient died in the next 12 months?".…”
Section: Overviewmentioning
confidence: 99%
“…El CPP estĂĄ indicado en un amplio margen de patologĂ­as, aun cuando la cura y la supervivencia a largo plazo, incluso hasta la vida adulta, son posibilidades viables [2,10]. En los niños, las enfermedades malignas (y algunas benignas), tales como fibrosis quĂ­stica, VIH, mucopolisacaridosis, enfermedades neurodegenerativas, entre otras, tienen un curso crĂłnico, y se han convertido en un problema de salud pĂșblica debido a la alta morbimortalidad que representan.…”
Section: Indicacionesunclassified
“…Como se puede observar, hoy en dĂ­a, el rango de pacientes que potencialmente se pueden beneficiar del CPP es muy amplio y heterogĂ©neo, justificando su empleo en forma adecuada desde los momentos iniciales de la enfermedad cuando se justifique, y no solo cuando la muerte del niño es el Ășnico desenlace posible [10]. En la Tabla 1 se pueden observar ejemplos de enfermedades en las cuales los niños se podrĂ­an beneficiar del CPP [13].…”
Section: Indicacionesunclassified
“…In pediatrics, parents and the healthcare team typically make decisions for patients, but as these patients become adolescents and young adults, they should voice their own values, opinions, and healthcare goals. In no area is this more important than in end‐of‐life care . Without knowing the patient's healthcare preferences in the case of advancing disease or imminent death, the family and healthcare team are forced to make decisions for the patient in an emotional and stressful time and in a culture that promotes life‐sustaining measures.…”
Section: Introductionmentioning
confidence: 99%
“…In no area is this more important than in end-of-life care. 3,4 Without knowing the patient's healthcare preferences in the case of advancing disease or imminent death, the family and healthcare team are forced to make decisions for the patient in an emotional and stressful time and in a culture that promotes lifesustaining measures.…”
mentioning
confidence: 99%